Navigation Links
Study Results of GAMMAGARD S/D and GAMMAGARD LIQUID in Patients with Mild-to-Moderate Alzheimer's Disease Announced
Date:4/17/2008

tal X-linked agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.

GAMMAGARD S/D must not be used in patients with selective IgA deficiency (IgA < 0.05 g/L) where the IgA deficiency is the only abnormality of concern.

Important Safety Information

Patients may experience severe hypersensitivity reactions or anaphylaxis in the setting of detectable IgA levels following infusion of GAMMAGARD S/D.

Immune Globulin Intravenous (Human) products have been reported to be associated with renal dysfunction, acute renal failure, osmotic nephrosis, and death. Patients predisposed to acute renal failure include patients with any degree of pre-existing renal insufficiency, diabetes mellitus, age greater than 65, volume depletion, sepsis, paraproteinemia, or patients receiving known nephrotoxic drugs. Especially in such patients, IGIV products should be administered at the minimum concentration available and the minimum rate of infusion practicable. While these reports of renal dysfunction and acute renal failure have been associated with the use of many of the licensed IGIV products, those containing sucrose as a stabilizer accounted for a disproportionate share of the total number.

GAMMAGARD S/D does not contain sucrose.

GAMMAGARD S/D is made from human plasma. It may carry a risk of transmitting infectious agents, e.g. viruses, and theoretically, the Creutzfeldt-Jakob disease (CJD) agent.

Aseptic meningitis syndrome (AMS) has been reported to occur infrequently in association with IGIV treatment. Discontinuation of IGIV treatment has resulted in remission of AMS within several days without sequelae.

Certain components used in the packaging of GAMMAGARD S/D contain natural rubber latex.

IGIV products can contain blood group antibodies that may cause a positive direct antiglobulin reaction and, rarely, hemolysis.

Thrombotic events have been report
'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... 2014 Research and Markets has ... Biomarkers in Alzheimer,s Disease: A Comprehensive Analysis and Market ... to their offering. This report is ... relating to early-stage minimally-invasive biomarkers in Alzheimer,s disease, which ... candidates in the AD drug pipeline, and applicable commercial ...
(Date:8/30/2014)... Mass. , Aug. 30, 2014  Boston ... its NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) ... clinical trial investigating vagus nerve stimulation (VNS) for ... M.D., Ph.D., Professor of Therapeutics and Cardiology and ... Institut National de la Sante et de la ...
(Date:8/30/2014)... , Aug. 30, 2014   Royal Philips  ... Affiniti, a new ultrasound system designed to ... demands of increasing patient volumes and cost pressures. Making ... 2014 in Barcelona this ... facing more patients with fewer resources deliver high quality ...
Breaking Medicine Technology:Early-Stage Minimally-Invasive Biomarkers in Alzheimer's Disease: A Comprehensive Analysis and Market Study of New Developments and Opportunities, 2014 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4
... 15 Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), ... present a company overview at the 17th Annual NewsMakers in ... 11:00 a.m. ET at the Millennium Broadway Hotel & Conference ... of the presentation will be available on the "Investors & ...
... Md., Oct. 15 /PRNewswire-Asia/ -- Synutra International, Inc. (Nasdaq: ... in China and a producer, marketer and seller of ... that the Company will present at Citi,s Greater China ... the Grand Hyatt Macau.  Management is currently scheduled to ...
Cached Medicine Technology:
(Date:9/1/2014)... As well as having completed the ... pursuing counselor certification in Louisiana. , "I ... training program as well as the Counselor training ... personally and professionally. I am not only dedicated ... to do so. As a Non Violent Crisis ...
(Date:9/1/2014)... The National Association of Hispanic Nurses ( ... DNP, MPH, RN, and Adriana Perez, PhD, Rn, ANP-BC, ... Nursing. They will be inducted with Immediate Past President ... we reported last May. , Our three members will ... American Academy of Nursing Policy Conference in Washington, DC. ...
(Date:9/1/2014)... 2014 BCC Research ( http://www.bccresearch.com ) ... TECHNOLOGIES AND GLOBAL MARKETS , the global market for ... and is expected to reach $38.7 million in 2014. ... by 2019, which is equivalent to 64.9% compound annual ... transport (RMT) segment is forecasted to grow at a ...
(Date:9/1/2014)... Bioinformatics refers to an interdisciplinary ... and genetic data. A major part of this ... tools to generate and process useful biological data. ... computation. While bioinformatics simply makes use of computers ... related concepts, biological computation refers to the subfield ...
(Date:9/1/2014)... In honor of National Take Your Cat to the Vet ... Center of Minnesota (AERC) is offering a few reasons why pet ... Many people don’t take their cat to the vet because “there’s ... wouldn’t decide not to take their kid to dentist because he ... for pets. Just like people want their loved ones to be ...
Breaking Medicine News(10 mins):Health News:Narconon Louisiana Announces New Certifications For Staff 2Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 2Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 4Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 2Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 2Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 3
... West Pharmaceutical,Services, Inc., (NYSE: WST ) today announced ... The meeting will be held on Tuesday, May 6,2008, ... can be accessed through the "Investor" section of,West,s web ... prior,to the live webcast to visit the site and ...
... new comparison of multi-national data, released this month, reveals ... than less educated women, but that the meaning of ... countries where malnutrition is prevalent, better-educated women weigh more. ... of obesity better-educated women weigh less. , ...
... Extensive Patent Portfolio, ANDOVER, Mass., April ... single sign-on (SSO), announced that it has ... technology upon which system,administration tooling for the ... automatically synchronizes multiple applications,in response to a ...
... struggle with,compulsive eating and other eating issues and are ... don,t know where to start. Overeaters,Anonymous (OA) has now ... path to recovery., Through a recently launched series ... now download information and personal,compelling stories of recovery from ...
... 30 The American Heart,Association recognized several distinguished ... 2008 "You,re The Cure on the Hill Awards ... The association presented its Gold Heart Award ... M.D., Augustus O. Grant, M.D., Ph.D.,and Reginald L. ...
... Acquisition Provides Bar Code Point-of-Care Technology to Enhance Patient ... Safety and Clinician Workflow Capabilities ... Inc.,(NYSE: HSP ), a global specialty pharmaceutical and ... that Hospira has,acquired Sculptor Developmental Technologies, a subsidiary of ...
Cached Medicine News:Health News:West Pharmaceutical Services, Inc. Announces Annual Meeting Webcast 2Health News:Better-educated women are a healthier weight, new research reveals 2Health News:Sentillion Receives U.S. Patent for Administering Context Management Systems 2Health News:Sentillion Receives U.S. Patent for Administering Context Management Systems 3Health News:Association Honors Top Volunteers, Staff Member at Washington, D.C. Meeting 2Health News:Association Honors Top Volunteers, Staff Member at Washington, D.C. Meeting 3Health News:Hospira Acquires Sculptor 2Health News:Hospira Acquires Sculptor 3
Bone cement with Gentamicin 2.5%....
... Techno-Aide provides the highest level of ... quality lead protective eyewear. Consistent ... tolerance allowed. Mfg supervised by Licensed ... lens meet or exceed standards for ...
... large designer goggle includes a ... providing a more comfortable, even ... The head strap design is ... The acrylic side shields provide ...
... base metal with gold electro-plate, the flex-temple ... adjustable non-slip silicon nose pads for maximum ... fitted lead sheet side shields that create ... increased scatter radiation protection. (Temples on this ...
Medicine Products: